FDA allows automatic 'generic' swap for brand-name insulinFDA allows automatic 'generic' swap for brand-name insulinFDA allows automatic 'generic' swap for brand-name insulin

FDA allows automatic 'generic' swap for brand-name insulin

It's the FDA's first approval of an "interchangeable" biosimilar, a near-copy of an injected biologic medicine that's manufactured inside living cells.

from Section Page News - Modern Healthcare https://ift.tt/3zQDAGX